In the News: Investors Turn to Invest in China's Secondary PE Market; Mad Dash for Chinese AI Pharma IPO; and China Issues New Carbon Emissions Measures

Jun 11, 2024
| By Krista Lee
International investors find Chinese secondary PE market an alternative amid U.S.-China tensions; QuantumPharm is the first IPO under Hong Kong’s new measure for pre-revenue specialist technology firms; and China releases new carbon measuring standards foreseeing new EU carbon tariffs.

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
 
Credit: Funtap/Adobe Stock

This premium content is reserved for
China Law & Practice Subscribers.

A Premium Subscription Provides:

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment

SUBSCRIBE NOW

Subscribe Now

For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected].